All-Assay-Max2 pQSAR: Activity Predictions as Accurate as Four-Concentration IC50s for 8558 Novartis Assays.

Profile-quantitative structure-activity relationship (pQSAR) is a massively multitask, two-step machine learning method with unprecedented scope, accuracy, and applicability domain. In step one, a "profile" of conventional single-assay random forest regression models are trained on a very large number of biochemical and cellular pIC50 assays using Morgan 2 substructural fingerprints as compound descriptors. In step two, a panel of partial least squares (PLS) models are built using the profile of pIC50 predictions from those random forest regression models as compound descriptors (hence the name). Previously described for a panel of 728 biochemical and cellular kinase assays, we have now built an enormous pQSAR from 11 805 diverse Novartis (NVS) IC50 and EC50 assays. This large number of assays, and hence of compound descriptors for PLS, dictated reducing the profile by only including random forest regression models whose predictions correlate with the assay being modeled. The random forest regression and pQSAR models were evaluated with our "realistically novel" held-out test set, whose median average similarity to the nearest training set member across the 11 805 assays was only 0.34, comparable to the novelty of compounds actually selected from virtual screens. For the 11 805 single-assay random forest regression models, the median correlation of prediction with the experiment was only rext2 = 0.05, virtually random, and only 8% of the models achieved our standard success threshold of rext2 = 0.30. For pQSAR, the median correlation was rext2 = 0.53, comparable to four-concentration experimental IC50s, and 72% of the models met our rext2 > 0.30 standard, totaling 8558 successful models. The successful models included assays from all of the 51 annotated target subclasses, as well as 4196 phenotypic assays, indicating that pQSAR can be applied to virtually any disease area. Every month, all models are updated to include new measurements, and predictions are made for 5.5 million NVS compounds, totaling 50 billion predictions. Common uses have included virtual screening, selectivity design, toxicity and promiscuity prediction, mechanism-of-action prediction, and others. Several such actual applications are described.